Index test:microRNA

4 trials

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University, The Second Affiliated Hospital of Fujian Medical University, Nanjing Second Hospital, Peking University Shenzhen Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)Renal cell carcinomaatrial fibrillationneonatal pneumonia

Early Phase 1

The role of serum MicroRNA in the diagnosis and treatment evaluation of neonatal pneumonia

Active, not recruitingChiCTR1900027343

The Second Affiliated Hospital of Fujian Medical Universityneonatal pneumonia

Start: 2019-12-01Updated: 2019-11-11

microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19)

RecruitingChiCTR2000030334

Nanjing Second HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-19Updated: 2020-03-02

Unknown Phase

The value of circulating non-coding RNAs as biomarkers in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation

Active, not recruitingChiCTR1900021341

Beijing Chao-Yang Hospital, Capital Medical Universityatrial fibrillation

Start: 2019-02-15Updated: 2019-02-18

A retrospective cohort study of microRNA in paraffin section to predict the prognosis of renal cell carcinoma

RecruitingChiCTR2100054597

Peking University Shenzhen HospitalRenal cell carcinoma

Start: 2021-12-21Updated: 2022-11-28

Related Papers

Leukocyte Telomere Length Predicts Progression From Paroxysmal to Persistent Atrial Fibrillation in the Long Term After Catheter Ablation

Frontiers in Cardiovascular Medicine2022-01-248 citations